Advancing Management Goals in Primary Biliary Cholangitis (PBC): Biochemical Control, Residual Risk and Symptom Burden
Nov
2026
World Class Speakers
Description
This interactive case-based session explores the evolving management goals in primary biliary cholangitis (PBC), highlighting the limitations of traditional biochemical response thresholds and the importance of residual risk assessment. Through real-world patient scenarios, faculty will examine alkaline phosphatase normalization, symptom burden, and comprehensive management strategies.
Industry Supporter: Ipsen